News About: Goverment
Cooperation Requested for Abrogated Restriction of Long-Term Prescription
Even though regulations that restrict long-term prescription were abrogated it was learned that patients' complaints still exist because some medical institutes apply the old rules due to lack of information.
In r...
Non-prescription drugs converted to non-NHI reimbursable scheme.
The MOHW has expanded the scope of non NHI reimbursable drugs in favorable agreement with the drug industry and pharmacy communities but a harsh backlash from the medical sector on the ground that this measure could b...
Drug registration possible even during drug reviewing period.
Any drugs belonging to the category of the government drug review program can be newly registered if the application documentations meet the requirement.
Accordingly, the KFDA is going to accept the above registrat...
1 Trillion won Will Be Allocated for Natural Products Development by 2010
An estimated 1 trillion won will be allocated for Natural New Medicine development for ten years from now on.
The Ministry of Health and Welfare announced a promotion plan for Natural Medicine development on Octobe...
1,403 non-prescription drugs put under non-NHI reimbursement scheme.
As one of the NHI financial saving plans the MOHW announced on Oct. 10 that 1,403 non-prescription drugs be excluded from the NHI reimbursement scheme, enforcing its effects gradually in 3 steps from Nov. this year to...
Substituted dispensing possible for other drugs proven of efficacy equivalent tests.
Until the medical community presents the common prescription drug lists to the pharmacist communities according to the newly revised provision, the substituted dispensing practices shall be followed under the old prov...
Excessive Prescription Restrained by means of Expanded General Medicine
The Ministry of Health and Welfare has announced that excessive prescription has been restrained because general medicine was excluded from insurance, and that in the case of light diseases if patients purchased relat...
Drugs without bio-equivalency proof to exit from markets.
Effective from Nov. this year under the new MOHW provision, the NHI reimbursement plan will not be applicable for the drugs that were not proven with their bio-equivalency. This may give a serious impact to the drug i...
Ban on backdoor dealings of insurance drugs reinforced.
The MOHW will prepare an improved plan for the current actual transaction price system and make an advanced announcement to the public prior to its enactment probably during the next week.
The above plan was presen...
KFDA Officially Launches Biomedicine Safety Department
The KFDA has officially launched the Biomedicine Safety Department, which is expected to contribute to safety management and new product development in the field of biomedicine.
The government announced that the r...
